Management of a large atrial septal occluder embolized to the left ventricular outflow tract without the use of cardiac surgery.

MedStar author(s):
Citation: Catheterization & Cardiovascular Interventions. 84(3):497-502, 2014 Sep 1.PMID: 24403086Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleSubject headings: *Cardiac Catheterization/mt [Methods] | *Device Removal/mt [Methods] | *Heart Septal Defects, Atrial/su [Surgery] | *Septal Occluder Device | Adult | Echocardiography, Transesophageal | Equipment Failure | Female | Follow-Up Studies | Heart Septal Defects, Atrial/di [Diagnosis] | HumansLocal holdings: Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006ISSN:
  • 1522-1946
Name of journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & InterventionsAbstract: Transcatheter closure of secundum-type atrial septal defects (ASDs) using the AMPLATZERTM Septal Occluder (ASO) has been in use for more than a decade since its US Food and Drug Administration approval in 2001. Device embolization remains an uncommon complication, which can sometimes occur after the initial deployment. Previous reports of ASO devices embolized to the left ventricle have primarily been managed by open-heart surgical retrieval. We present a case of an ASO device embolized to the left ventricular outflow tract (LVOT) 18 hr after initial implantation, which was successfully retrieved percutaneously, followed by successful closure of the ASD using a larger device.Copyright © 2014 Wiley Periodicals, Inc.All authors: Loh JP, Satler LF, Slack MCDigital Object Identifier: Date added to catalog: 2015-06-03
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article Available 24403086

Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006

Transcatheter closure of secundum-type atrial septal defects (ASDs) using the AMPLATZERTM Septal Occluder (ASO) has been in use for more than a decade since its US Food and Drug Administration approval in 2001. Device embolization remains an uncommon complication, which can sometimes occur after the initial deployment. Previous reports of ASO devices embolized to the left ventricle have primarily been managed by open-heart surgical retrieval. We present a case of an ASO device embolized to the left ventricular outflow tract (LVOT) 18 hr after initial implantation, which was successfully retrieved percutaneously, followed by successful closure of the ASD using a larger device.Copyright © 2014 Wiley Periodicals, Inc.

English

Powered by Koha